Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Alysa Kasen, Christina Houck, Amanda R. Burmeister, et al.
Neurobiology of Disease (2022) Vol. 166, pp. 105654-105654
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 545
The heterogeneity of Parkinson’s disease
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 67
α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Lia‐Raluca Olari, Sichen Liu, Franziska Arnold, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 35
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
Lorenzo Agostino Citterio, Roberta Mancuso, Simone Agostini, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 865-865
Open Access | Times Cited: 23
Immunosenescence and Inflammaging: Mechanisms and Role in Diseases
Amir Ajoolabady, Domenico Praticò, Daolin Tang, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102540-102540
Closed Access | Times Cited: 11
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
Armin Bayati, Riham Ayoubi, Adriana Aguila, et al.
Nature Neuroscience (2024)
Closed Access | Times Cited: 10
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré, Robert H. Edwards, Glenda M. Halliday, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 9
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Luca Soraci, Maria Elsa Gambuzza, Leonardo Biscetti, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1346-1360
Open Access | Times Cited: 30
Oral and intestinal dysbiosis in Parkinson's disease
E. Berthouzoz, Vladimir Lazarević, Alkisti Zekeridou, et al.
Revue Neurologique (2023) Vol. 179, Iss. 9, pp. 937-946
Open Access | Times Cited: 20
Systemic inflammation and risk of Parkinson’s disease: A prospective cohort study and genetic analysis
Chunyu Li, Bin Ke, Jianhai Chen, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 447-455
Closed Access | Times Cited: 8
Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model
Cara Sophie Schreiber, Ivo Wiesweg, Stephanie Stanelle-Bertram, et al.
EBioMedicine (2024) Vol. 105, pp. 105191-105191
Open Access | Times Cited: 8
Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
Florian Ermini, Victoria F. Low, Jennifer J. Song, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Ran Zheng, Yiqun Yan, Shaobing Dai, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
Kathryn G. Sterling, Griffin Kutler Dodd, Shatha Alhamdi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13328-13328
Open Access | Times Cited: 19
Pathophysiological Significance of α-Synuclein in Sympathetic Nerves
Risa Isonaka, Patti Sullivan, David S. Goldstein
Neurology (2025) Vol. 104, Iss. 3
Closed Access
The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies
Mohammad Yasin Zamanian, Zahra Kamran, Marziye Ranjbar Tavakoli, et al.
Molecular Neurobiology (2025)
Closed Access
Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility
Liu Li, Yan Zhao, Weixing Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2079-2079
Open Access
The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson’s disease
Yuan-Kai Cheng, Hao-Sen Chiang
Neurological Sciences (2025)
Closed Access
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease
Shakila Yaribash, Keyhan Mohammadi, Mahmood Alizadeh Sani
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Dimitrios S. Mysiris, George D. Vavougios, Eirini Karamichali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9739-9739
Open Access | Times Cited: 16
Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans
Wouter Peelaerts, Veerle Baekelandt
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 67-82
Closed Access | Times Cited: 9
A functional role for alpha-synuclein in neuroimmune responses
Dustin L. Heiden, Brendan Monogue, Muhammad Ali, et al.
Journal of Neuroimmunology (2023) Vol. 376, pp. 578047-578047
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top